Novo Nordisk - Oxford Fellowship Programme
The Novo Nordisk – Oxford Fellowship Programme aims to support the development of a new generation of exceptional researchers in the field of diabetes and other cardiometabolic diseases, who will become future leaders in the field.
Contact us
-
-
Kathleen Dolan
Research Facilitator and Novo Nordisk Programme Manager (maternity cover)
+44 1865 231458
-
Julia Humes
Research Facilitator and Novo Nordisk Fellowship Operations Manager (Maternity Cover)
Supported by
Our aim
The Novo Nordisk – Oxford Fellowship Programme is focused on research in diabetes, cardiometabolism, liver and renal disease. It aims to support the development of a new generation of exceptional early career researchers, who will become future leaders in the field, while further developing scientific excellence and ultimately improving the lives of patients. We offer prestigious 3-year postdoctoral research fellowship positions in research projects that span the translational spectrum, from basic biological research through to clinical application.
What we offer
We offer fellows a cutting edge research project based at the University of Oxford, which is supervised by world-leading researchers in the field of diabetes and other cardiometabolic diseases. In addition, each fellow is given a mentor or supervisor at Novo Nordisk. There is also the opportunity to spend time in the laboratories of Novo Nordisk (both in Oxford and Denmark). This distribution of time will depend on the fellow's specific project. Fellows will therefore get an insight into research in both academia and industry.
Latest publications
-
Assessing the effect of anesthetic gas mixtures on hyperpolarized 13 C pyruvate metabolism in the rat brain.
Journal article
Healicon R. et al, (2022), Magn Reson Med
-
Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents
Journal article
Hazlehurst JM. et al, (2022), Metabolism Open, 100177 - 100177
-
Magnetic Resonance pH Imaging in Stroke – Combining the Old with the New
Journal article
LARKIN J. et al, (2022), Frontiers in Physiology
-
Concentration dependent effects of dichloroacetate in type-2 diabetic hearts assessed by hyperpolarized [1-13 C]-pyruvate MRI.
Journal article
Szocska Hansen ES. et al, (2021), NMR in biomedicine